RECKITT BENCKISER GROUP PLC ORD – Consensus Indicates Potential 12.4% Upside

Broker Ratings

RECKITT BENCKISER GROUP PLC ORD found using the EPIC (LON:RB) have now 18 analysts covering the company.The range between the high target price and low target price is between £90.00 and £51. with the average target price sitting at £70.86. Now with the previous closing price of £63.06 this indicates there is a potential upside of 12.4%. There is a 50 day moving average of £63.85 and the 200 day MA is £69.57. The market capitalisation for the company is £45b. You can visit the company’s website by visiting:

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands. It also provides analgesics; footcare and footwear products; sore throat medications; and women’s beauty products under the Nurofen, Scholl, Strepsils, and Veet brand. In addition, the company offers fragrances and devices; water softeners; home cleaning products; dish washes; toilet bowl cleaners; disinfectants; sprays, baits, and plug-ins for pest control; stain removals; and fabric washing products under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands, as well as infant and child nutrition products under the Enfamil and Nutramigen brands. It operates in the United States, Canada, Europe, Russia/CIS, Turkey, Israel, Australia, New Zealand, and internationally. The company was founded in 1823 and is headquartered in Slough, the United Kingdom.

Good news travels fast (but only if you make that happen):

Share on twitter
Share on linkedin
Share on facebook
Share on email
Share on whatsapp